WALLDORF, Germany, Oct. 6 /PRNewswire-FirstCall/ -- SAP AG (NYSE: SAP)
today announced that John Papandrea has joined SAP as senior vice president
of the Healthcare industry business unit. In this position, effective
August 1, 2008, Mr. Papandrea will help drive SAP's industry leadership
efforts in providing strategic software solutions to healthcare
organizations around the world. The announcement was made in conjunction
with the 3rd annual Ambassadors Dinner and the U.S.-EU eHealth Conference,
both organized by the European-American Business Council in Brussels and
Paris.

"With his immense business management experience, Mr. Papandrea will be
a tremendous asset to SAP and to our customers in the healthcare industry,"
said Bob Stutz, head of Industries Solutions and corporate officer of SAP.
"We consider healthcare as one of our most important growth markets in the
years to come. I am in particular delighted that John brings his in-depth
knowledge of the U.S. healthcare market -- the largest single healthcare
market worldwide."

Bringing vast experience managing people and resources, as well as
building business cases for information technology investments in
healthcare, Mr. Papandrea joins SAP from Deloitte Consulting, where he
advised large healthcare organizations on information technology strategy,
effective use of technology and technology innovation.

Previously, John Papandrea worked with Capgemini and Ernst & Young,
driving strategic partner relationships and advising clients on the value
derived from the use of information technology in healthcare, particularly
in the clinical arena.

John Papandrea holds a bachelor's degree in biomedical science from the
University of Technology Sydney, and a master's degree in Health
Administration from the University of New South Wales, both located in
Sydney, Australia.

Photos of John Papandrea are available. Please contact one of the media
contacts mentioned in this announcement.

Any statements contained in this document that are not historical facts
are forward-looking statements as defined in the U.S. Private Securities
Litigation Reform Act of 1995. Words such as "anticipate," "believe,"
"estimate," "expect," "forecast," "intend," "may," "plan," "project,"
"predict," "should" and "will" and similar expressions as they relate to
SAP are intended to identify such forward-looking statements. SAP
undertakes no obligation to publicly update or revise any forward-looking
statements. All forward-looking statements are subject to various risks and
uncertainties that could cause actual results to differ materially from
expectations. The factors that could affect SAP's future financial results
are discussed more fully in SAP's filings with the U.S. Securities and
Exchange Commission ("SEC"), including SAP's most recent Annual Report on
Form 20-F filed with the SEC. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of their
dates.

Copyright (C) 2008 SAP AG. All rights reserved.

SAP, R/3, mySAP, mySAP.com, xApps, xApp, SAP NetWeaver and other SAP
products and services mentioned herein as well as their respective logos
are trademarks or registered trademarks of SAP AG in Germany and in several
other countries all over the world. All other product and service names
mentioned are the trademarks of their respective companies. Data contained
in this document serve informational purposes only. National product
specifications may vary.

(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...

(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...

(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...

(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...

(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...

(Date:12/8/2016)... Pa. , Dec. 8, 2016 Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...